Jacob Rotmensch, MD
Jacob Rotmensch, MD
Professor & Section Chief
Rush University Medical Center
5732 South Kenwood Avenue
Chicago,
IL
USA
60637
Papers:
A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study